Daniel L. Reuvers - 23 Mar 2026 Form 4 Insider Report for Neuronetics, Inc. (STIM)

Reporting relationship: President and CEO
Issuer ticker: STIM
Reported as of: 23 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Mar 2026, 16:41:42 UTC
Prior SEC filing: 13 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Patrick Devine, as Attorney-in-Fact

Key filing fact

Daniel L. Reuvers filed Form 4 for Neuronetics, Inc. (STIM) on 23 Mar 2026.

Key facts

This page summarizes Daniel L. Reuvers's Form 4 filing for Neuronetics, Inc. (STIM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Mar 2026, 16:41.

Change

Previous filing in this sequence was filed on 13 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001563602 Primary reporting owner

REUVERS DANIEL L.

Relationship: President and CEO
Address: C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN
Signature: /s/ Patrick Devine, as Attorney-in-Fact
Signature date: 23 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STIM transaction

Common Stock

Award

Transaction value
Shares: +1,500,000
Change %
Price: $0.000000^*
Shares after: 1,500,000
Date: 23 Mar 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award that vests in three equal annual installments beginning on March 23, 2027, in each case subject to continuous service of the Reporting Person through such date.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's common stock.